Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$98,875,920
+$9,922,324 QoQ
Shares Held
1,716,000
+17.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#110
of 2,506 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,791,248,361 across 11 Drug Manufacturers - General names. BMY ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
726,199 | $871,024,939 | |
| 2 | JNJ |
Johnson & Johnson
|
2,566,595 | $651,838,132 | |
| 3 | ABBV |
AbbVie Inc.
|
1,598,568 | $402,263,651 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,030,023 | $260,857,955 | |
| 5 | AMGN |
Amgen Inc
|
471,833 | $170,860,165 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,071,977 | $135,433,574 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
1,716,000 | $98,875,920 | |
| 8 | PFE |
Pfizer Inc
|
3,801,302 | $91,535,352 |
All Filings in BMY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,875,920 | 1,716,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $88,953,596 | 1,466,671 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,365,135 | 433,169 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $26,160,751 | 580,061 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,071,173 | 195,964 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $119,068,825 | 1,952,268 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $439,427,479 | 7,769,227 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $232,528,148 | 4,494,166 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $36,198,960 | 871,634 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $9,297,311 | 160,188 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $28,619,346 | 412,918 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $61,428,463 | 853,766 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $158,245,984 | 2,225,995 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $76,773,620 | 997,060 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $41,393,404 | 566,800 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $31,418,165 | 503,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $48,131,185 | 813,439 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $91,726,419 | 1,372,739 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $90,852,845 | 1,439,139 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $117,003,405 | 1,886,239 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $133,590,823 | 2,215,804 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $122,476,888 | 2,197,289 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||